United Therapeutics (UTHR) Moves 12.6% Higher: Will This Strength Last?Zacks Investment Research • 10/01/26
United Therapeutics Corporation Prevails in Patent Litigation Against LiquidiaBusiness Wire • 09/30/26
United Just Pulled The Ultimate Bull Move, As Its Chief Rival CollapsedInvestors Business Daily • 09/30/26
United Therapeutics Corporation (UTHR) Presents at Bernstein Insights: Healthcare Leaders and Disruptors - 3rd Annual Healthcare Forum TranscriptSeeking Alpha • 09/23/26
United Therapeutics Corporation (UTHR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/14/26
United Therapeutics Corporation (UTHR) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference TranscriptSeeking Alpha • 09/09/26
United Therapeutics Corporation (UTHR) Presents at Wells Fargo 21st Annual Healthcare Conference TranscriptSeeking Alpha • 09/08/26
United Therapeutics Corporation Announces Accelerated Share Repurchase Agreement for Remainder of $2.0 Billion AuthorizationBusiness Wire • 09/08/26
United Therapeutics (UTHR) Down 8% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 09/04/26
FDA Accepts UTHR's sNDA for Tyvaso in Idiopathic Pulmonary FibrosisZacks Investment Research • 09/03/26
United Therapeutics Corporation Announces FDA Acceptance of Supplemental New Drug Application for Nebulized Tyvaso® to Treat Idiopathic Pulmonary FibrosisBusiness Wire • 09/02/26
United Therapeutics Presents Data at The European Society of Cardiology Congress 2026 and The European Respiratory Society International Congress 2026Business Wire • 08/28/26
United Therapeutics Corporation Announces FDA Filing Acceptance of New Drug Application for Ralinepag to Treat Pulmonary Arterial HypertensionBusiness Wire • 08/24/26
UTHR Completes Phase III Tyvaso Study Enrollment for Expanded LabelZacks Investment Research • 08/18/26
United Therapeutics Corporation Announces Full Enrollment of the TETON-PPF Study of Inhaled Treprostinil for the Treatment of Progressive Pulmonary FibrosisBusiness Wire • 08/17/26
United Therapeutics Q2 Earnings Beat Estimates, Revenues Miss MarkZacks Investment Research • 08/06/26
United Therapeutics (UTHR) Reports Q2 Earnings: What Key Metrics Have to SayZacks Investment Research • 08/05/26